Effectiveness of digital care platform CMyLife for patients with chronic myeloid leukemia: results of a patient-preference trial

• Published in: BMC health services research Vol. 23; no. 1; pp. 228 - 14
• Main Authors: Verweij, Lynn, Ector, Geneviève I. C. G., Smit, Yolba, van Vlijmen, Bas, van der Reijden, Bert A., Hermens, Rosella P. M. G., Blijlevens, Nicole M. A.
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 08.03.2023; BioMed Central; BMC
• Subjects: Analysis; Care and treatment; Chronic Disease; Chronic illnesses; Chronic myeloid leukemia; CML; COVID-19; Digital care platform; Disease; Empowerment; Guideline adherence; Health care access; Health services; Hospitals; Humans; Information provision; Kinases; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy; Life expectancy; Literacy; Medical care; Medication compliance; Methods; Online health care information services; Pandemics; Patient compliance; Patient empowerment; Patients; Personal health; Quality management; Quality of Life; Questionnaires; Remission (Medicine); Self report; Technology application; Netherlands; Guideline adherence; CML; Molecular monitoring; Information provision; Digital care platform; Medication compliance; Patient empowerment; Quality of life

Two most important factors determining treatment success in chronic myeloid leukemia (CML) are adequate medication compliance and molecular monitoring albeit still being suboptimal. The CMyLife platform is an eHealth innovation, co-created with and for CML patients, aiming to improve their care, lea...